Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA User Fee Bill Up For Final Senate Action After House Passage

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate is last step before the bill goes to the president; Rep. Dingell laments that legislators were “closer than ever before” on a tracking agreement but did not quite make it.

Advertisement

Related Content

Budget Reductions Target FDA Field Operations
Budget Reductions Target FDA Field Operations
FDA Field Operations Would Endure Reductions Under Budget
Senate Prevails On PDUFA Antibiotic Incentive As House Vote Nears
Inspection Fees Face Tough Road In Congress As PhRMA Remains Opposed

Topics

Advertisement
UsernamePublicRestriction

Register

PS074313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel